Skip to main content

GOLDMAN SACHS GROUP INC

Position in AUTL — Autolus Therapeutics plc

CIK 886982 NEW YORK, NY

Position in AUTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$181,689
+$21,040 QoQ
Shares Held
113,556
-2.5% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 84 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. AUTL ranks #316 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AUTL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $181,689 113,556
2026-03-31 $160,649 116,413
2025-12-31 $55,220 27,749
2025-09-30 $804,817 493,753
2025-06-30 $54,961 24,106
2025-03-31 $78,137 50,411
2024-12-31 $296,640 126,230
2024-09-30 $217,843 60,012
2024-06-30 $272,706 78,364
2024-03-31 $1,380,255 216,341
2023-12-31 $848,347 131,731
2023-09-30 $155,692 66,821
2023-06-30 $221,804 93,195
2023-03-31 $40,143 21,817
2022-09-30 $40,341 18,851
2022-06-30 $59,540 21,039
2022-03-31 $1,565,893 375,514
2021-12-31 $796,254 153,421
2021-09-30 $369,361 56,391
2021-06-30 $4,319,293 650,496
2021-03-31 $65,860 11,494
2020-12-31 $128,601 14,385
2020-09-30 $320,961 27,574
2020-06-30 $555,150 34,632
2020-03-31 $229,944 38,388